JPRN-UMIN000014477招募中1 期
Feasibility study of pemetrexed / bevacizumab / erlotinib in chemotherapy naïve patients with non- small cell lung cancer harboring EGFR mutation - Feasibility Study of pemetrexed / bevacizumab / erlotinib
ational Hospital Organization Kyushu Medical Center,Department of Respiratory Medicine0 个研究点目标入组 12 人开始时间: 2014年7月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Interstitial pneumonia/lung fibrosis on chest X-ray 2)History of chest radiation therapy 3)History or complication of hemoptysis with 2.5ml per time or more and Continuous bloody phlegm more than 1 week or complication of bloody phlegm treated with continuous oral hemostatic agent. History or complication of bloody phlegm treated with infusional hemostatic agent. 4)Evidence of tumor invading a perihilar blood vessel, heart and major blood vessel on imaging 5)Evidence of tumor invading segmental bronchus 6)Symptomatic brain metastasis 7)Active hepatic disease 8)Having serious complications 9)Uncontrolled ascites, pleural effusion or cardiac effusion 10) History of multiple malignancies within 3 years 11) Planning of surgery during the trial 12) A pregnant woman, a nursing girl and woman with the possibility (intention) of the pregnancy, and 13) Having serious mental disorder 14) Previous drug allergy 15) Those judged to be not suitable by the attending physician
研究者
相似试验
已完成
不适用
A feasibility study of Pemetrexed/Bevacizumab in elderly patients with advanced non-small cell lung cancer (TORG1015)on-small cell lung cancerJPRN-UMIN000004263Thoracic Oncology Research Group12
招募中
2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000008781Toho university medical center sakura hospital25
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
已完成
2 期
Phase II study of Pemetrexed plus Bevacizumab (YCRG04) in exacerbation cases of Non-squamous Non-small cell lung cancer, previously treated with bevacizumab plus platinum-based chemotherapy.on-Squamous Non-Small Cell Lung CancerJPRN-UMIN000006721Yokohama City University Medical Center45